Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 35 min ago
Peer-reviewedLicence not statedHypertension (Dallas, Tex. : 1979)

HuR inhibition attenuates hypertension and fibrosis in chronic kidney disease

4 affiliations
  1. 1Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USA.
  2. 2Department of Nutrition and Integrative Physiology and Molecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
  3. 3Department of Chemical Biology and Medical Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  4. 4Department of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.

Related

  1. Dapagliflozin attenuates progression from prefrailty to frailty in patients with hypertension and chronic kidney disease.
    Pasquale Mone, Davide Viggiano, Antonella Pansini +13
    The Journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Enhancer of Zeste Homolog 2 Inhibition Attenuates Atrial Fibrillation Post-Myocardial Infarction Through Reduced Atrial Fibrosis
    Tian-Peng Wei, Wen-Rui Wang, Xiao-Lu Zhang +6
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Group IVA Cytosolic Phospholipase A2 (cPLA2α): Pharmacological Inhibition Attenuates Kidney Inflammation and Fibrosis
    Berit Johansen, Said Movahedi Naini, Linn-Karina Selvik +9
    BiomoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  4. Dapagliflozin Attenuates Post-Infarction Myocardial Fibrosis Associated With the Inhibition of NLRP3-Dependent Inflammation
    Xiao Han, Jun Zhang, Pingchang Guo +13
    Reviews in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  5. Physical activity attenuates mortality risk associated with elevated resting heart rate in chronic kidney disease
    Ya Zhan, Bin He, Lei Pu +3
    ISciencePeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMCCrossref
BibTeX
@article{zhuang2026inhibition,
  title = {{HuR inhibition attenuates hypertension and fibrosis in chronic kidney disease}},
  author = {Lili Zhuang and Zhou Wang and Ziwei Fu and Sohom Mookherjee M. and J. David Symons and Jeffrey Aube and Xiaoqing Wu and Liang Xu and Yufeng Huang},
  journal = {Hypertension (Dallas, Tex. : 1979)},
  year = {2026},
  month = nov,
  doi = {10.1161/hypertensionaha.126.26933},
  url = {https://doi.org/10.1161/hypertensionaha.126.26933},
}
RIS
TY  - JOUR
TI  - HuR inhibition attenuates hypertension and fibrosis in chronic kidney disease
AU  - Lili Zhuang
AU  - Zhou Wang
AU  - Ziwei Fu
AU  - Sohom Mookherjee M.
AU  - J. David Symons
AU  - Jeffrey Aube
AU  - Xiaoqing Wu
AU  - Liang Xu
AU  - Yufeng Huang
PY  - 2026
DA  - 2026/11/10
JO  - Hypertension (Dallas, Tex. : 1979)
DO  - 10.1161/hypertensionaha.126.26933
UR  - https://doi.org/10.1161/hypertensionaha.126.26933
SN  - 0194-911X
SN  - 1524-4563
ER  -